AP Health Writer WASHINGTON (AP) — Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos Therapeutics announced the FDA’s decision on Friday. Supporters of psychedelic therapy hoped that MDMA would make history as the first illegal psychedelic to win FDA approval, paving the way for similar drugs to enter the medical mainstream. But FDA’s rejection was widely expected after a negative review of the drug in June. Government advisers voted overwhelmingly against the drug’s approval, citing questionable study data and allegations of research misconduct. The post FDA won’t approve psychedelic MDMA for PTSD, calling for additional s
Hence then, the article about fda won t approve psychedelic mdma for ptsd calling for additional study was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA won’t approve psychedelic MDMA for PTSD, calling for additional study )